摘要
目的观察万托林雾化吸入治疗急性哮喘患儿的疗效与安全性。方法将74例年龄在7～12岁间的急性支气管哮喘患儿分为四组。治疗剂量A组雾化吸入0.3 mL 0.5%万托林;B组采用0.4 mL 0.5%万托林;C组采用0.5 mL 0.5%万托林;对照组吸入硫酸特布他林气雾剂。观察各组症状、体征消失时间、疗效及对心率影响等不良反应。结果 A、B、C组治疗后总有效率分别为73.7%、88.9%、94.4%,B、C组与对照组的总有效率相比,差异有统计学意义(P<0.05)。C组不良反应有所增加,A、B组未出现明显副作用。结论依据不同剂量万托林总有效率及不良反应情况,B组为急性哮喘患儿的最佳治疗剂量。
Objective To observe the efficacy and safety of ventolin aerosol inhalation therapy in children with acute asthma.Methods Seventy-four cases children aged between 7-12 years with acute bronchial asthma were divided into four groups.Therapeutic dose of group A was 0.3 mL of 0.5% ventolin atomization inhalation,and doses of group B and group C were 0.4 and 0.5 mL of 0.5% ventolin,respectively.Control group inhaled sulfuric acid terbutaline aerosol.Observed the symptoms,signs disappeared,and its effect on heart rate and adverse reaction of each group.Results The total effective rates of group A,B,C were 73.7%,88.9% and 94.4%,respectively.Conpared with control group,group B and C had significant different（P〈0.05）.The side effect of group C increased,but that of group B and C was not obvious.Conclusion According to the side-effect and total efficiency of each group,we knew that group B was the best clinical dosage of ventolin for acute bronchial asthma in children.
出处
《中国现代医生》
2013年第10期63-64,共2页
China Modern Doctor
基金
浙江省中医药重点研究计划(2011ZB044)
关键词
支气管哮喘
心率
万托林
雾化吸入
Bronchial asthma
Heart rate
Ventolin
Aerosol inhalation
